Aktina Medical Corp

Aktina Medical Corp specializes in accessories and components for linear accelerator (LINAC) quality assurance (QA) used in radiation therapy and radiosurgery. Their products include reticles, graticules, overlay systems, tabletop accessories, and machine vision tools like the PinPoint System and PositionPro Component. These devices are designed to improve precision in imaging, treatment planning, and alignment verification, ensuring accuracy during patient treatment. Examples include film graticules for port film analysis and a CT overlay system for alignment checks.

Aktina Medical Corp is based in the United States. Their devices are listed in two key regulatory registries: the FDA’s 510(k) database and the EU’s eudamed registry. These registries track medical devices that have undergone the necessary regulatory processes for market authorization, ensuring transparency and compliance with global standards.

Aktina Medical Corp’s devices are classified under FDA regulations as Class I, Class II, Class IIa, and Class IIb. The classification determines the regulatory pathway and level of scrutiny required for market authorization. For example, Class II devices typically require a 510(k) premarket notification submission to demonstrate substantial equivalence to a legally marketed predicate device, while Class I devices may involve general controls or exemptions. The classification ensures appropriate oversight based on the device’s risk level.

Aktina Medical Corp’s machine vision tools, such as the PinPoint System and PositionPro Component, are designed to enhance precision in radiation therapy and radiosurgery by automating and improving imaging accuracy. These tools integrate with LINAC systems to assist in treatment planning, alignment verification, and real-time monitoring of patient positioning. By reducing human error and increasing consistency, they help ensure that radiation doses are delivered with the highest possible accuracy, which is critical for effective and safe patient outcomes.